Combination therapy with ivonescimab for EGFR-positive NSCLC

This Medudy course is a video tutorial for physicians on the topic of "Combination therapy with ivonescimab in EGFR-positive NSCLC". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the standard first-line treatment for patients with non-small cell lung cancer (NSCLC) [...].
Diagnostic procedures for lung lesions

This Medudy course is a video tutorial for physicians on the topic of "Diagnostic procedures for pulmonary lesions", in which we summarize the latest and most important clinical studies for you. This Medudy course is a video tutorial for physicians. The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most [...]
IL-4-mediated immunotherapy resistance in ovarian cancer

This Medudy course is a video tutorial for physicians on the topic of "IL-4-mediated immunotherapy resistance in ovarian cancer". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Immune checkpoint blockade therapies have shown limited success in ovarian cancer. This therapy resistance is mediated by the immunosuppressive tumor microenvironment (TME) [...]
Cervical cancer screening using DNA methylation triage

This Medudy course is a video tutorial for physicians on the topic of "Cervical cancer screening using DNA methylation triage". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Cervical cancer screening, particularly with HPV vaccination, is key to prevention but relies on the [...]
Inflammation levels, lipids and long-term cardiovascular outcomes in women

This Medudy course is a video tutorial for physicians on the topic of "Inflammation, lipids and long-term cardiovascular outcomes in women". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Cardiovascular risk can be assessed over 5 and 10 years on the basis of [...]